Neumora Therapeutics, Inc. (NMRA) Insider Trading

Name: Neumora Therapeutics, Inc. (NMRA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 21, 2026): Daljit Singh Aurora (Chief Operating and Development Officer): Exercise/Conversion of 67,741 shares, $48.8K.

Get alerted when insiders trade NMRA

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta